Learn More
Human CXCL13/BLC/BCA-1 Antibody, R&D Systems™

Description
Specifications
Specifications
| Antigen | CXCL13/BLC/BCA-1 |
| Applications | Western Blot, Immunohistochemistry, Neutralization |
| Classification | Polyclonal |
| Concentration | LYOPH |
| Conjugate | Unconjugated |
| Dilution | Western Blot 0.1 ug/mL, Immunohistochemistry 5-15 ug/mL, Neutralization 1-4 ug/mL |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative |
| Gene Accession No. | Q53X90 |
| Gene Alias | ANGIE, ANGIE2, B cell-attracting chemokine 1, B lymphocyte chemoattractant, BCA1, BCA-1, BCA1B-cell chemoattractant, BCA-1CXC chemokine BLC, B-cell-homing chemokine (ligand for Burkitt's lymphoma receptor-1), BLC, BLCSmall-inducible cytokine B13, BLR1L, B-lymphocyte chemoattractant, chemokine (C-X-C motif) ligand 13, chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant), C-X-C motif chemokine 13, SCYB13, SCYB13B-cell-attracting chemokine 1, small inducible cytokine B subfamily (Cys-X-Cys motif), member 13 (B-cellchemoattractant) |
| Gene Symbols | CXCL13 |
| Show More |
For Research Use Only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.